Cureza Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-07-2024
- Paid Up Capital ₹ 1.00 M
as on 09-07-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.18 Cr
as on 09-07-2024
- Revenue 193.49%
(FY 2023)
- Profit 1812.23%
(FY 2023)
- Ebitda 1395.62%
(FY 2023)
- Net Worth 1063.29%
(FY 2023)
- Total Assets 132.98%
(FY 2023)
About Cureza Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹8.18 Cr.
Sagar Khatuja and Anil Kukreja serve as directors at the Company.
- CIN/LLPIN
U74999MP2018PTC046858
- Company No.
046858
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Gwalior, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cureza Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar Khatuja  | Director | 12-Oct-2018 | Current |
| Anil Kukreja | Director | 12-Oct-2018 | Current |
Financial Performance of Cureza Healthcare.
Cureza Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 193.49% increase. The company also saw a substantial improvement in profitability, with a 1812.23% increase in profit. The company's net worth Soared by an impressive increase of 1063.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cureza Healthcare?
Unlock access to Cureza Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Crossasia Biotech Private LimitedActive 2 months 17 daysSagar Khatuja and Anil Kukreja are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 04 Dec 2023 | ₹6.50 Cr | Open |
Others Creation Date: 19 Jul 2022 | ₹1.51 Cr | Open |
Hdfc Bank Limited Creation Date: 21 May 2022 | ₹1.66 M | Open |
How Many Employees Work at Cureza Healthcare?
Unlock and access historical data on people associated with Cureza Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cureza Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cureza Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
